Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
RadNet sees potential midsize and larger acquisitions on its horizon
Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Once physicians confirm a patient's CAD risk is low, they can feel comfortable putting diagnostic testing on hold.

Cigna is removing 25% of medical services from prior authorization, but none of them are in imaging

The health insurer has faced criticism over its use of PA, including a class action lawsuit alleging it denied claims for imaging and other healthcare services in bulk

Solis Mammography acquiring network of breast imaging centers

Supported by Chicago-based Madison Dearborn Capital Partners, the company has grown rapidly in recent years to now include 100-plus locations.

Private equity-backed LucidHealth touts new 2-year partnership track for its growing teleradiology group

Since 2020, the “virtual practice” has grown to include more than 75 physicians operating across 47 states, with leaders seeking to hire more.

Industry Watcher’s Digest

Buzzworthy developments of the past few days.

Artificial Intelligence GPU chips demand

AI launches Nvidia’s earnings toward the stratosphere—and investors toward their calculators

Whichever AI segment you follow most closely, be it healthcare or any other, you had to pause to absorb this week’s financial report from Nvidia.

The Medtronic Symplicity Spyral Renal Denervation system uses a catheter that curls in the renal artery to place radiofrequency electrodes against the vessel wall to ablate the nerves that control vasodilation, so the artery can be propped in the fully open position.

FDA panel votes not to endorse Medtronic renal denervation system

The vote was close, initially ending with a tie, but the panel ultimately decided there were too many questions related to the device's long-term benefits for patients with uncontrolled hypertension.

FDA temporarily halts mammography services at critical access hospital, claiming they posed ‘serious risk to human health’

Phelps Memorial Health Center has completed the necessary remedies, including notifying any women who underwent breast imaging the last two years.

Management

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology

RadNet sees potential midsize and larger acquisitions on its horizon